Care for patients with ventricular assist devices and suspected COVID-19 infection
- PMID: 32437041
- PMCID: PMC7280643
- DOI: 10.1002/ejhf.1907
Care for patients with ventricular assist devices and suspected COVID-19 infection
Figures
Comment on
-
The Imperfect Cytokine Storm: Severe COVID-19 With ARDS in a Patient on Durable LVAD Support.JACC Case Rep. 2020 Jul 15;2(9):1315-1320. doi: 10.1016/j.jaccas.2020.04.001. Epub 2020 Apr 8. JACC Case Rep. 2020. PMID: 32292915 Free PMC article.
References
-
- Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail 2017;19:595–602. - PubMed
-
- Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, Jain SS, Burkhoff D, Kumaraiah D, Rabbani L, Schwartz A, Uriel N. COVID‐19 and cardiovascular disease. Circulation 2020;141:1648–1655. - PubMed
-
- Yamani MH, Chuang HH, Ozduran V, Avery RK, Mawhorter SD, Cook DJ, Zilka C, Zeroske K, Buda T, Hobbs RE, Taylor DO, Smedira NG, Starling RC. The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation. J Heart Lung Transplant 2006;25:820–824. - PubMed
-
- Ahmad T, Wang T, O'Brien EC, Samsky MD, Pura JA, Lokhnygina Y, Rogers JG, Hernandez AF, Craig D, Bowles DE, Milano CA, Shah SH, Januzzi JL, Felker GM, Patel CB. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. JACC Heart Fail 2015;3:30–39. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical